Notícias e Atividades da Catalyst Pharmaceuticals

Catalyst Pharmaceuticals é uma das ...

• Russell 3000;
• TOB Iconic 10,000.

Catalyst Pharmaceuticals é uma empresa listada sob o símbolo CPRX (US).

Veja o organograma con seus 17 executivos principais

Biografias mais buscadas da Catalyst Pharmaceuticals

• Richard Daly, Director and Chief Executive Officer
• Patrick McEnany, Non-Executive Chairman of the Board
• David Tierney, Director

Recentes movimentos de executivos em Catalyst Pharmaceuticals

• Charles O'Keeffe, Lead Independent Director, deixará a Companhia em mai. de 2025  (Notícia publicada em 28 de janeiro de 2025).

Criar um alerta
para seguir os movimentos de executivos da Catalyst Pharmaceuticals.

Catalyst Pharmaceuticals possui 1.825 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Eli Lilly (Estados Unidos).

Popular M&A news in Farmacêutica

• Chimerix and Chimerix have merged  (publicado em 22 de abril de 2025)..
• Imbria Pharmaceuticals acaba de anunciar uma arrecadação de fundos de 58 milhões de dólares. (publicado em 10 de abril de 2025).
• Clario adquiriu NRx Pharmaceuticals (publicado em 18 de março de 2025).

Outros contatos sugeridos na indústria do Farmacêutica

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets da Bristol-Myers Squibb
• Kristin Berkinsky - Chief Human Resources Officer da Adare Pharmaceuticals
• Jean-Michel Demeure - Vice President, Finance Global Operations da Sanofi

Saiba mais sobre a indústria do Farmacêutica

Últimos comunicados de imprensa de Catalyst Pharmaceuticals

• Catalyst Pharmaceuticals To Participate in Piper Sandler 35th Annual Healthcare Conference : Catalyst Pharmaceutical
• Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update : Catalyst Pharmaceutical
• Press Releases : Catalyst Pharmaceutical
• Catalyst Pharmaceuticals Reports FDA Approval of AGAMREE® (vamorolone) for Duchenne Muscular Dystrophy Granted to Santhera Pharmaceuticals : Catalyst Pharmaceutical
• Catalyst Pharmaceuticals Receives Two New U.S. Patent Allowances For FIRDAPSE® : Catalyst Pharmaceutical
• Catalyst Pharmaceuticals Partners with Sofie's Journey to Bring Focus on Epilepsy at the 11th Annual Epilepsy Awareness and Education Expo : Catalyst Pharmaceutical
• Catalyst Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 8, 2023 : Catalyst Pharmaceutical
• Catalyst Pharmaceuticals to Participate at the 2023 Cantor Global Healthcare Conference : Catalyst Pharmaceutical
• Catalyst Pharmaceuticals Announces FDA Acceptance of the Supplemental New Drug Application for FIRDAPSE® : Catalyst Pharmaceutical
• Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer : Catalyst Pharmaceutical
• View more press releases Close

Redes sociais sobre Catalyst Pharmaceuticals

• Catalyst Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
• Catalyst Pharmaceuticals na LinkedIn, Twitter e YouTube